ARTICLE | Finance
Takeda’s math problem
Why a winning bid for Shire could be a Pyrrhic victory for Takeda
April 21, 2018 12:44 AM UTC
A hefty net debt load of $18.8 billion for Shire plc (LSE:SHP; NASDAQ:SHPG) means Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) is having to pick its poison to reach a deal.
The Japanese pharma is grappling with giving away more than half its company to Shire’s investors, or pushing its postmerger debt levels to potentially dangerous heights...